MMJ to Expand Land for Greenhouse Cannabis Production
Published 03-AUG-2016 13:08 P.M.
|
2 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
MMJ Phytotech (ASX:MMJ) has executed a binding Letter of Intent (LOI) with Cowichan Tribes (the largest single First Nation Band in British Columbia) to lease 13 acres of land directly adjacent to its Duncan Facility in Canada. The extra land would significantly expand MMJ’s production capacity.
While the terms of the lease are still under negotiation, MMJ estimates the extra land could support up to 10 acres of greenhouse production space potentially yielding over 25,000kg a year of cannabis – more than 25 times the current production capabilities at the Duncan Facility.
The Duncan Facility currently only produces 1000kg of cannabis per year, but the extra land would position MMJ as one of the largest cannabis cultivation operations in Canada.
“The company is pleased to have entered this strategic land expansion agreement for our Duncan Facility, which provides the land access which would be required for the requisite scale for MMJ to become one of the largest producers of cannabis globally,” said MMJ Managing Director Andreas Gideon.
Land expansion would not only increase production capacity, it would also strengthen MMJ’s supply chain and play a key role in supplying the soon-to-be-legalised Canadian recreational market.
Conservative estimates for recreational sales are approximately CAD$5 million (AU$5.01) and with only 29 companies licensed to produce medical cannabis in Canada, MMJ is in a first mover position to target the recreational market.
MMJ is yet to tap this market, however, so if considering MMJ as an investment option, base your decision on all information with regard to this company and seek professional financial advice.
MMJ has agreed to pay Cowichan Tribes CAD$1000 per month until the expiry of the option agreement in 1 June 2017, or the entry into a lease agreement. MMJ will also work with Cowichan Tribes to identify any employment opportunities at current or expanded operations for Cowichan community members.
The land has been vacant for several years, but was previously used for commercial greenhouse growing operations. MMJ will adopt a similar greenhouse growing system to those implemented by licensed producers including the $153 million capped Aphria Inc. (CVE:APH) and Tweed Farms Inc., which has a 350000 sq ft greenhouse in the heart of the Niagara region. By adopting this approach MMJ expects capital costs to be much lower than with traditional indoor cannabis cultivation facilities.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
